Aurobindo Pharma Subsidiary CuraTeQ Receives Health Canada NOC for Bevacizumab Biosimilar Bevqolva 01/05/2026 / Material Events / Biosimilar Drug Approval Aurobindo Pharma Subsidiary CuraTeQ Receives Health Canada NOC for Bevacizumab Biosimilar Bevqolva Read Post ยป
